NCT05548296: A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
- State
- Under way
- Phase
- Phase 2
- People
- 350 planned
- Started
- 29 Aug 2022
- Primary completion
- 30 May 2027
- Arms
- OncoSignature Positive Tumors
- Results
- None posted
- 29 Aug 2022: Trial started
- 21 Sep 2022: Trial registered